/ /

Ophthalmology Times Staff Reports
ARVO: Change of scenery with ‘Life-changing research’ focus
With a change of venue and scenery, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) hits the road this year, moving from its long-time home in Fort Lauderdale, FL, to Seattle. With a central theme of “Life-changing research,” the 2013 conference will focus on how vision researchers make a difference.
OWL honors award recipients
Ophthalmic Women Leaders (OWL) honored the recipients of three awards at its annual Monday night reception during the 2013 meeting of the American Society of Cataract and Refractive Surgery.
Subconjunctival implant: 2-year data
Two-year data on a subconjunctival implant suggest that the device is both safe and effective in lowering IOP in both refractory glaucoma and early stages of the disease. Results from the multicenter, international study were presented by Steven Vold, MD.
Liquid ocular bandage results positive
An ocular bandage that has been on the market in Europe for several years is receiving praise from clinicians familiar with the product. Matteo Piovella, MD, has been using the bandage on every eye he has operated on for the past 4 years.
Sustained-release medications on the way
A new generation of drug delivery devices promises to make eye drops the drug delivery vehicle of the past, according to Ike K. Ahmed, MD, assistant professor at the University of Toronto.
Limbal deficiency more common than realized
Limbal stem cell deficiency is more common than often recognized, said Edward Holland, MD, director of Cornea Service at the Cincinnati Eye Institute and professor at the University of Cincinnati in Cincinnati.
Taking an evidence-based approach to dry eye
Much of the guesswork about how to manage dry eye disease was clarified by the results of the Dry Eye Workshop, which established a practical, easy-to-use assessment tool and stepwise treatment approach, said Deepinder Dhaliwal, MD, associate professor of ophthalmology and director, Cornea and Refractive Surgery at the University of Pittsburgh Medical Center.
Implanting iris prosthesis is ‘in the bag’
Early data on an artificial iris implant suggest positive clinical and cosmetic outcomes. Findings from a retrospective non-comparative case series of 74 eyes in 57 patients offered positive results for patients who received a custom flexible silicone prosthesis for iris defects resulting from a variety of different causes, said Michael Snyder, MD, Cincinnati Eye Institute, Blue Ash, OH.
Flap shape makes difference
There is more to femtosecond laser LASIK than the laser frequency alone. Flap shape also makes a difference. A recent trial confirmed that elliptical flaps offer the predicted surgical advantages over circular flaps with no change in patient satisfaction or visual performance scores, said Louis Probst, MD,
Two stents safe, effective
If one trabecular bypass stent is good for reducing IOP, are two stents better? The answer could be yes, at least for a first-generation device (iStent, Glaukos). Data presented showed that microinvasive glaucoma surgery (MIGS) to implant two trabecular micro-bypass stents is safe and effective after 1 year of follow-up.

Poll

View Results